Department of Psychiatry

Riggs, P.D., Mikulich-Gilbertson, S.K., Davies, R.D., Lohman, M., Klein, C., Stover, S.K. A Randomized Controlled Trial of Fluoxetine and Cognitive Behavioral Therapy in Adolescents with Major Depression, Behavior Problems, and Substance Use Disorders Archives of Pediatric and Adolescent Medicine, 161 (11): 1-9, 2007.

Libby, A.M., Orton, H.D., Stover, S.K., Riggs, P.D. What Came First, Major Depression or Substance Abuse Disorder? Clinical Characteristics and Substance Use Comparing Teens in a Treatment Cohort. Addictive Behaviors, 30: 1649-1662, 2005.

Whitmore, E.A. and Riggs, P.D. “Adolescent Substance Use Disorders and Comorbid Conditions: Developmentally Informed Diagnostic and Treatment Considerations” Chapter 15 in: Treating Adolescent Substance Abuse: State of the Science. H. Liddle and C. Rowe (Eds.), Cambridge, UK: Cambridge University Press, 2005.

Libby A.M. and Riggs, P.D. Integrated Substance Use and Mental Health Treatment for Adolescents: Aligning Organizational and Financial Incentives. Journal of Child and Adolescent Psychopharmacology, 15(5): 826-834, 2005.

Riggs P.D., Hall S.K., Mikulich-Gilbertson S.K., Lohman M., Kayser A. A Randomized Controlled Trial of Pemoline for ADHD in Substance Abusing Adolescents. J Am Acad Child Adolescent Psychiatry, 43(4): 420-429, 2004.

Riggs, P.D. Treating Adolescents for Substance Use and Comorbid Psychiatric Disorders. Science & Practice Perspectives, 2(1):18-29, 2003. NIH/NIDA publication.

Riggs P.D. and Davies R.D. A Clinical Approach to Integrating Treatment for Adolescent Depression and Substance Abuse. J Am Acad Child Adolescent Psychiatry. 41(10): 1253-1255, 2002.

Title: Bupropion for ADHD in Adolescents with Substance Use Disorders
The primary aims of this study are: 1) To assess the safety and efficacy of bupropion versus placebo in treating ADHD in adolescents with SUD; 2) To assess the safety and efficacy of bupropion versus placebo in reducing nicotine use in adolescents with ADHD and SUD. Secondary Aims: 3) To evaluate the impact of bupropion versus placebo on non-nicotine drug use (including cannabis); 4) To evaluate the impact of bupropion versus placebo on depressive symptoms in the subsample who meet DSM-IV criteria for major depressive disorder (MDD).
Role:Principal Investigator
1R01 DA022284-01A1
NIH/NIDA
Dates: 08/15/2008-06/30/2013

Title: Clinical Trials Network, Ohio Valley Node
Dr. Riggs', UCD PI, involvement with the Clinical Trials Network continues via a subaward arrangement with the University of Cincinnati/ Ohio Valley Node. The protocol: "A Randomized Controlled Trial of Osmotic-Release Methylphenidate (OROS-MPH) for Attention Deficit Hyperactivity Disorder in Adolescents with Substance Use Disorders" (CTN-0028), the conduct of which is supported under this subaward.
Role: Principal Investigator
U10 DA013732-09 (Somoza)
NIH/NIDA (UCD Subcontract)
Dates: 09/30/2000-08/31/2010

Title: Martial Arts as Early Intervention for Teen Drug Abuse
Role: Co-Investigator
R01 DA018679
Dates: 2006 - 2009

Title: NIDA Enters College: Infusing the Science of Addiction into University Curricula
Role: Co-Investigator
R25 DA020472
Dates: 2006-2010

Title: NIDA /AACAP Physician Scientist Program in Substance Abuse
Role: Principal Investigator
K12 DA000357
Dates: 2004 - 2009

Title: NIDA Clinical Trials Network, Rocky Mountain Clinical Trials Node
Role: Principal Investigator
U10 DA013716
Dates: 2005 - 2008

Title: NIDA Clinical Trials Network, Ohio Valley Node
Role: Co-Investigator
U10 DA013732
Dates: 2005 - 2008

Title: Center on Anti-Social Drug Dependence
Role: Co-Investigator
DA 011015
Dates: 2005 - 2006

Title: NIDA Clinical Trials Network, Rocky Mountain Clinical Trials Node
Role: Principal Investigator
U10 DA013716
Dates: 2002 - 2005

Title: NIDA Substance Dependent Teens: Impact of Treating Depression
Role: Principal Investigator
R01 DA013176
Dates: 2000 - 2007

Title: NIDA/AACAP Physician Scientist Program in Substance Abuse
Role: Co-Investigator, consultant/no salary support
K12 DA000357
Dates: 1998 - 2004

Title: NIDA Center Grant, Antisocial Drug Dependence: Genetics to Treatment
Role: Principal Investigator: Component VI
P60 DA011015
Dates: 1997 - 2002

Title: Pemoline: Effect on Drug Abuse in Delinquents with ADHD
Role: Principal Investigator
NIDA Scientist Development Award (K20 DA00271)
Dates: 1995 - 2001

Title: NIDA Substance Use and Conduct Disorder: Motility & Neuropsychiatry
Role: Co-Investigator
R01 DA09842
Dates: 1995 - 2000

Medical Students:
Tutor, Big Six Substance Abuse Problems in Primary Care Medicine (Psych 8001). This is a 2 – 4 week full-time elective course for 3rd and 4th year medical students. It aims to introduce students to the detection, evaluation, and treatment of the most important substance issues in primary care medicine. Tutors are members of the Division of Substance Dependence and community practitioners.

Psychiatric Residents:
Course Director, Adolescent Substance Use Disorders and Co-Occurring Disorders; Child, Adolescent Residency Training Program, UCD. 1996- present.

Course Director, Development 1; General Psychiatry Residency Training Program, UCD. 1996-2006.

Lecturer, Introduction to Substance Dependence for PGY III Residents. This course meets for 1 hr / week for 10 weeks each year. Teachers are faculty in the Division of Substance Dependence and community practitioners. Scheduled Lectures in 2007.

Mentoring:
Dr. Riggs also serves as the Principal Investigator of the NIDA/ AACAP K 12 Physician Scientist Career Development Program currently offering research training to five Child and Adolescent Psychiatrists establishing independent addiction research careers.

Dr. Riggs serves as an elective research mentor to Residents in the Department of Psychiatry, UCD and to Post-Doctoral Fellows through the Developmental Psychobiology Research Group (DPRG) research fellowship.

Mentor, Psychiatry Scholars Program, Division Faculty serve as mentors to medical students wishing to fulfill their independent learning requirement.

Opportunities for Research Participation of Medical Students and Residents:
Medical Students: In the Division’s research elective, Psychiatry 8610, or Psychiatry Scholars Program, students will work on projects currently pursued by Division faculty, or in associated labs on the CU-Boulder campus.

Residents and Post-Doctoral Fellows: Dr. Riggs serves as an elective research mentor to Residents in the Department of Psychiatry, UCD and to Post-Doctoral Fellows through the Developmental Psychobiology Research Group (DPRG) research fellowship.